Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Group Regulatory News (ASHM)

Share Price Information for Ashmore Group (ASHM)

Share Price is delayed by 15 minutes
Get Live Data
202.60    0.00 (0.00%)
Bid:
202.40
Ask:
203.20
Spread: 0.80 (0.395%)
Market Cap: £1.32b
ASHM Live PriceLast checked at - London Stock Exchange

Intraday Ashmore Group Share Chart

Trading Statement

15 Jan 2019 07:00

RNS Number : 0698N
Ashmore Group PLC
15 January 2019
 

Ashmore Group plc15 January 2019

SECOND QUARTER ASSETS UNDER MANAGEMENT STATEMENT

Ashmore Group plc ("Ashmore", "the Group"), the specialist Emerging Markets asset manager, announces the following update to its assets under management ("AuM") in respect of the quarter ended 31 December 2018.

Assets under management

Theme

Actual30 September 2018

(US$ billion)

Estimated31 December 2018

(US$ billion)

Movement

(%)1

External debt1

15.5

15.5

-1.9%

Local currency

17.2

17.5

+1.2%

Corporate debt

10.6

10.8

+1.8%

Blended debt

20.4

20.4

-

Equities1

4.0

4.4

+3.3%

Alternatives

1.7

1.6

-3.5%

Multi-asset1

1.0

0.4

+0.8%

Overlay / liquidity

6.0

6.1

+1.9%

Total

76.4

76.7

+0.4%

1. During the period, a multi-asset fund was reclassified into its constituent elements of external debt and equity. The % movement in the period is stated excluding the effect of this reclassification.

 

Assets under management increased by US$0.3 billion during the period, through net inflows of US$0.5 billion and negative investment performance of US$0.2 billion.

Net inflows were delivered in the corporate debt, blended debt, equities, multi-asset and overlay/liquidity themes. There was a small net outflow in the local currency theme, and the external debt and alternatives themes were flat during the period.

Investment performance was modestly negative in aggregate for the three-month period reflecting the weaker global market conditions in October, with positive performance delivered over the rest of the quarter. Local currency delivered positive investment performance, benefiting from a weakening US dollar, and performance was flat in equities, corporate debt and overlay/liquidity. Each of the other themes had slightly negative performance over the three months. Against the backdrop of weak and volatile markets for much of 2018, and consistent with Ashmore's value-based investment philosophy, investment processes have added risk to take advantage of the indiscriminate mispricing of assets and, as is typical at such points, there is some moderate underperformance over the shorter term. Ashmore's performance relative to benchmarks over three and five years remains strong.

Mark Coombs, Chief Executive Officer, Ashmore Group plc, commented:

"Despite the more challenging markets experienced for much of 2018, client flows remain resilient reflecting investors' very low allocations to Emerging Markets and recognition of the value available. The effect of tax-related stimulus on the US economy and its support for the US dollar started to fade towards the year end, removing the main headwind for Emerging Markets outperformance. The reduction in Emerging Markets asset prices despite improving economic growth suggests underweight investors will continue increasing allocations to Emerging Markets, and a return to the positive market trends experienced in 2016 and 2017."

 

Notes

For the translation of US dollar-denominated balance sheet items, the GBP:USD exchange rate was 1.2736 at 31 December 2018 (30 June 2018: 1.3200; 31 December 2017: 1.3513). For the translation of US dollar management fees, the average GBP:USD exchange rate achieved for the first half of the financial year was 1.2948 (H1 2017/18: 1.3259).

The investment performance figure of US$0.2 billion includes the effect of translating non-US dollar share classes or funds into US dollars for reporting purposes. Over the quarter, this resulted in a negative contribution to reported investment performance of US$0.1 billion.

Ashmore will announce its interim results in respect of the six months ending 31 December 2018 on 14 February 2019.

Ashmore's Legal Entity Identifier (LEI) is 549300U3L59WB4YI2X12.

 

For further information please contact:

Ashmore Group plcPaul MeasdayInvestor Relations +44 (0)20 3077 6278

FTI ConsultingNeil Doyle +44 (0)20 3727 1141Laura Ewart +44 (0)20 3727 1160

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLLFLTLVISLIA
Date   Source Headline
14th Aug 20185:16 pmRNSHolding(s) in Company
13th Jul 20187:00 amRNSTrading Statement
2nd Jul 20188:44 amRNSDirectorate Change
20th Apr 20184:30 pmRNSDirector/PDMR Shareholding
17th Apr 20187:00 amRNSTrading Statement
4th Apr 20184:32 pmRNSDirector/PDMR Shareholding
29th Mar 20184:00 pmRNSDirector/PDMR Shareholding
8th Feb 20187:00 amRNSHalf-year Report
16th Jan 20187:00 amRNSTrading Statement
6th Dec 20171:55 pmRNSDirectorate Change
5th Dec 201711:45 amRNSDirector/PDMR Shareholding
5th Dec 201710:57 amRNSDirector/PDMR Shareholding
20th Oct 20173:08 pmRNSResult of AGM
13th Oct 20174:49 pmRNSDirector/PDMR Shareholding
13th Oct 20177:00 amRNSTrading Statement
19th Sep 20172:11 pmRNSDirector/PDMR Shareholding
19th Sep 20172:07 pmRNSDirector/PDMR Shareholding
7th Sep 20177:00 amRNSFinal Results
14th Jul 20177:00 amRNSTrading Statement
16th Jun 20177:00 amRNSInvestor presentation
21st Apr 20174:30 pmRNSDirector/PDMR Shareholding
18th Apr 20177:00 amRNSTrading Statement
10th Apr 20175:19 pmRNSDirector/PDMR Shareholding
29th Mar 20179:23 amRNSHolding(s) in Company
28th Mar 20174:54 pmRNSDirector/PDMR Shareholding
9th Feb 20177:00 amRNSHalf-year Report
16th Jan 20177:00 amRNSTrading Statement
21st Oct 20163:57 pmRNSResult of AGM
14th Oct 20167:00 amRNSTrading Statement
21st Sep 20164:30 pmRNSDirector/PDMR Shareholding
21st Sep 20164:30 pmRNSDirector/PDMR Shareholding
6th Sep 20167:00 amRNSFinal Results
10th Aug 201610:45 amRNSHolding(s) in Company
14th Jul 20167:00 amRNSTrading Statement
18th May 201610:00 amRNSAppointment of joint corporate broker
20th Apr 20164:28 pmRNSHolding(s) in Company
19th Apr 20167:00 amRNSTrading Statement
15th Apr 20164:39 pmRNSHolding(s) in Company
4th Apr 20168:56 amRNSDirector/PDMR Shareholding
24th Mar 20165:30 pmRNSDirector/PDMR Shareholding
23rd Mar 20168:21 amRNSHolding(s) in Company
11th Feb 20167:00 amRNSHalf Yearly Report
14th Jan 20167:00 amRNSTrading Statement
11th Dec 20155:30 pmRNSDirector/PDMR Shareholding
11th Dec 20155:28 pmRNSDirectorate Change
7th Dec 201510:13 amRNSDirector/PDMR Shareholding
13th Nov 20159:15 amRNSDirector/PDMR Shareholding
28th Oct 201511:56 amRNSForm 8.3 - Al Noor Hospitals Group PLC
28th Oct 201511:52 amRNSForm 8.3 - NMC Health plc
27th Oct 20154:42 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.